Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002823 · ClinicalTrials.gov registry record · Phase 3
Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer
A Phase 3 study, sponsored by Gustave Roussy, Cancer Campus, Grand Paris.
- Completed
- Registry status
- Phase 3
- Development phase
- 3,300
- Enrollment target
NCT00002823: Completed Phase 3 study, sponsored by Gustave Roussy, Cancer Campus, Grand Paris.
NCT00002823 is a Phase 3 study that has completed, run by Gustave Roussy, Cancer Campus, Grand Paris. The registered enrollment target is 3,300 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (327% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002823, a Phase 3 study, has completed, sponsored by Gustave Roussy, Cancer Campus, Grand Paris.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 3,300 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if combination chemotherapy given after surgery is more effective than surgery alone for non-small cell lung cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy following surgery with that of surgery alone in treating patients who have stage I, stage II, or stage IIIA non-small cell lung cancer.
Interventions
- DRUG cisplatin
- DRUG etoposide
- DRUG vinorelbine tartrate
- DRUG vinblastine sulfate
- DRUG vindesine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,300 participants |
| Start Date | 1995-02 |
| Phase | Phase 3 |
What the finished NCT00002823 record still lists
NCT00002823 is an interventional study that assigns participants to a tested intervention. Its 3,300 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (327% higher).
The record links to 0 conditions, and to 5 interventions - of which cisplatin is the first listed.
NCT00002823 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002823 about?
NCT00002823 is a clinical study titled "Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if combination chemotherapy given after surgery is more effective than surgery alone for non-small cell lung cancer. PURPOSE: Randomized phase III trial to com...
What is the current status of trial NCT00002823?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 3,300 participants. The study started on 1995-02.
What interventions are being tested in trial NCT00002823?
The interventions under investigation include: cisplatin (DRUG), etoposide (DRUG), vinorelbine tartrate (DRUG), vinblastine sulfate (DRUG), vindesine (DRUG).
Who is sponsoring clinical trial NCT00002823?
This trial is sponsored by Gustave Roussy, Cancer Campus, Grand Paris, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00002823's enrollment target sits among peer trials
3,300 72nd of 2000 higher than 1,929 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07214610 · 3,300 participants · NA
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
- NCT03674307 · 3,306 participants · NA
Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates
- NCT06815536 · 3,291 participants
Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin-Resistant Neisseria Gonorrhoeae
- NCT06543446 · 3,290 participants · NA
Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia